Choosing Among Common Data Models for Real‐World Data Analyses Fit for Making Decisions About the Effectiveness of Medical Products-Reference-Cited by-同舟云学术

Choosing Among Common Data Models for Real‐World Data Analyses Fit for Making Decisions About the Effectiveness of Medical Products

Published:2019-08-25 Issue:4 Volume:107 Page:827-833
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Schneeweiss Sebastian¹,Brown Jeff S.²,Bate Andrew³,Trifirò Gianluca⁴,Bartels Dorothee B.⁵

Affiliation:

1. Division of Pharmacoepidemiology and Pharmacoeconomics Department of Medicine Brigham and Women's Hospital and Harvard Medical School Boston Massachusetts USA

2. Department of Population Medicine Harvard Medical School and Harvard Pilgrim Health Care Institute Boston Massachusetts USA

3. Pfizer Ltd Walton Oaks UK

4. Department of Biomedical and Dental Sciences and Morphofunctional Imaging University of Messina Messina Italy

5. BI X GmbH Boehringer Ingelheim Ingelheim Germany

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1577

Reference52 articles.

1. Multidimensional Evidence Generation and FDA Regulatory Decision Making

2. A review of uses of health care utilization databases for epidemiologic research on therapeutics

3. Primary Medication Non-Adherence: Analysis of 195,930 Electronic Prescriptions

4. Prospective Postmarketing Surveillance of Acute Myocardial Infarction in New Users of Saxagliptin: A Population-Based Study

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antihypertensive therapy during pregnancy: the prescription pattern in Italy;Frontiers in Pharmacology;2024-08-30

2. A Comprehensive Framework for Evaluating the Value Created by Real-World Evidence for Diverse Stakeholders: The Case for Coordinated Registry Networks;Therapeutic Innovation & Regulatory Science;2024-07-25

3. Transparency, reproducibility, and replicability of pharmacoepidemiology studies in a distributed network environment;Pharmacoepidemiology and Drug Safety;2024-05-23

4. Metric identification and mapping of reimbursable implant codes in Morocco to the global nomenclature (GMDN) and European (EUDAMED) of medical devices;Annales Pharmaceutiques Françaises;2024-05

5. Hypothetical Assessments of Trial Emulations;JAMA Internal Medicine;2024-04-01